Eupraxia Pharmaceuticals Announces New Positive Data From RESOLVE Phase 1B/2A Trial Of EP-104GI For Treatment Of Eosinophilic Esophagitis
Source: menafn.com
Stay updated with breaking news from Second Cohorts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.